Skip to content
FIND A HEALTH VALLEY ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

Latest BioAlps news

Adaptyv raises $40M Series A to build the automated lab for agentic biology

The Biopôle-based startup announced a $40M Series A funding round to build the automated lab for agentic biology, led by…

Spineart Announces FDA Approval ofBAGUERA® C Cervical Disc

Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the…

Atinary in Boston

Bruker expands its collaboration with Atinary and makes a minority investment

Bruker Corporation (NASDAQ:BRKR) announced that it is expanding its strategic collaboration with Atinary Technologies Inc., and acquiring a minority stake…

Alcon

Alcon Halts Intraocular Lens Programmes After $402 Million Writedown

Alcon, the Geneva-based global leader in eye care, announced on Monday evening that it is discontinuing its intraocular lens (IOL)…

Oculis

Oculis Secures FDA Backing and Full Ownership of Privosegtor

Oculis Holding AG, a Zug-based biopharmaceutical company with operations in Lausanne, has had a decisive first two weeks of August…

SOPHiA GENETICS ASTRA ZENECA

SOPHiA GENETICS Enters Collaboration With AstraZeneca to Develop Companion Diagnostics for Precision Oncology Therapies

The Vaud-based AI-native healthcare technology company announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx)…

Timeline

Timeline Wins $5.3 Million Court Judgment Against Fake Urolithin A Sellers

Timeline (Amazentis SA), the Lausanne-Based life-sciences company behind the postbiotic ingredient Urolithin A and its branded form Mitopure®, has secured…

Haya Therapeutics

HAYA Therapeutics granted Fast Track designation by the FDA for HTX-001

HAYA Therapeutics SA, a clinical-stage biotechnology company based in Lausanne and San Diego, announced that the US Food and Drug…

AB2 Bio

AB2 Bio Secures $30 Million as Nippon Shinyaku Exercises US Commercialization Rights for Tadekinig Alfa

AB2 Bio, a Swiss Health Valley and EPFL based company, has announced that Nippon Shinyaku has exercised its exclusive option…

HeroSupport

HeroSupport Starts Clinical Study With NYU Grossman School of Medicine

HeroSupport SA is a UNIGE and HUG spin out and created VENUS SHELL™ , a 3D-printed support that enables accurate,…

Sprin-D Challenge

Impli and Molesense Selected for Germany’s SPRIND Continuous Hormone Monitoring Challenge

MoleSense and Impli, two startups based at Biopôle near Lausanne, have both been selected by Germany’s Federal Agency for Breakthrough…

Planimetrics

Planimetrics Receives CHF 40,000 from Venture Kick

Planimetrics, formerly Laxiped, is a life-sciences project, spun out University of Geneva (UNIGE) and Assal Center, working on a solution…